Department of Pathology, University Hospital and Medical Center, State University of New
York at Stony Brook, Stony Brook,
NY 11794 and Department of Laboratories, North Shore
University Hospital
- NYU School of
Medicine,
Manhasset, NY 11030
Strains within the subfamily Spumavirus (“foamy viruses”, “foamy agent’) in the
Family Retroviridae, are common infectious agents in primates and cell cultures
derived
from these animals (13,18). Spumavirus proviral DNA, antibodies and/or
infectious particles, have been detected in humans, specifically among
accidentally exposed laboratory personnel (1,11). Although
Spumavirus strains
are not considered human pathogens, the ability of this retrovirus to affect long
term human infections has elicited concern among some medical professionals
(17). Accordingly, a need exists to define the infectivity/persistence of this virus in
commonly used laboratory media, water, and viricidal agents.
The infectivity/persistence of a previously characterized Spumavirus strain
(Asian Old World monkey Strain SV-522; 7), was investigated in common
laboratory media, reagents, viricidal agents, and water, which consisted of
Earle’s minimal essential medium (EMEM) containing 0% fetal bovine serum
(EMEM-0%), EMEM-2%, EMEM-10%, heat inactivated and non-heat inactivated
human serum; Chlamydia
transport medium (CTM), phosphate-buffered saline
(PBS), distilled, estuarine, and marine water, 70% ethyl alcohol, and 10% sodium
hypochlorite.
Infectivity titers were monitored at time zero to periods up to 10
and/or
23o
C (5).
Spumavirus was reisolated from all media and waters after 5 days at 23o
C,
and in EMEM-10% after 7 days (Fig. 1). The virus was detected in CTM, EMEM-
2%, EMEM- 10%, estuarine and marine waters after 7 days at 4o
C (Fig. 2).
Enhanced viral persistence at reduced temperatures and in the presence of
elevated concentrations of organic supplements in media, have long been
recognized
(4,12). The failure to discern differences in Spumavirus infectivity at
C in the presence or absence of organic media supplements (except EMEM-
10%) notwithstanding, may be explained by a masking effect imparted by the
suboptimal maintenance temperature.
Our data show no long term survival of
Spumavirus in distilled, estuarine, or
marine waters (i.e., the virus was not detected after 7 days) . These pure system
studies concur with earlier reports, wherein increased salinity and media of
differing ionic strengths, afforded no significant viral stabilizing effects (6,8,21).
Spumavirus infectivity was undetectable after 30 s in the presence of 70%
ethanol or 10%
sodium hypochlorite. Ethanol solubilizes viral envelope
phospholipids. Sodium hypochlorite, serves as a strong oxidizing agent, similarly
rendering the virus innocuous (19,23). Such chemically induced loss of viral
infectivity has been described earlier utilizing the related human
immunodeficiency virus type 1 (HIV-1; 10,14).
After a 30 min incubation at 23o
C, Spumavirus infectivity in normal but not
heat-inactivated human serum was found to increase by a factor of almost 2 log
10
(viz., 5.4 X 106
vs 3.6 X 104
TCID
/ml, respectively). Among other retroviruses
50
such as,
the HIV-1 and
the human T-cell leukemia/lymphoma virus type 1
(HTLV-1) , deposition of early complement breakdown products on the surface of
cell-free particles have been suggested to enhance binding to complement
;
Enhanced
in vitro infectivity
in turn, has been
shown to occur (15,22). Inasmuch as human fibroblasts contain CR+
sites, along
with the Spumavirus being refractory in part to complement inactivation, it would
not be unreasonable to speculate that enhanced Spumavirus infectivity might
similarly reflect the virion’s interaction with one or more complement system
products in human serum (3,9,20).
These data report for the first time, the effect of common laboratory media,
viricidal agents, and selected pure system environmental waters, on the
infectivity/persistence of
Spumavirus. Among the media/waters tested, virus
infectivity was reduced to non-detectable levels after 5 to 7 days. 70% ethanol
and 10% sodium hypochlorite, were identified as highly effective viricidal agents.
Normal, but not heat-inactivated human serum affected a viral enhancement
effect.
Due to the recognized infectious capability of Spumavirus and its persistence
up to 7 days in commonly used media and waters, appropriate precautionary
measures are needed among laboratorians involved with the
preparation/manipulation of primate cell/organ cultures, and in the handling and
care of primates themselves.
P.A. Sandstrom. 1999. Persistent zoonotic infection of a human with simian
foamy virus in the absence of an intact orf-2 accessory gene. J. Virol. 73:
9619-9624.
2. Flugel, R. M. 1993. The Molecular Biology of Human Spumavirus. p. 193-214.
In: B. R. Cullin (ed.). Human Retroviruses.Oxford University Press, Inc., New
York.
3. Hooks, J. J., W. Burns, K. Hayashi, S. Gels, and K. Notkins, 1976. Viral spread
in the presence of neutralizing antibody:mechanism of persistence in foamy
virus infection. Infect. Immun. 14: 1172-1178.
4. Johnson, F. B. 1990. Transport of viral specimens. Clin. Microbiol. Rev. 3:
120-131.
5. Lipson, S. M. 1992. The Neutralization Test. In: HD Isenberg, (ed.). Clinical
Microbiology Procedures Handbook. Amer. Soc. Microbiol., Washington, DC.
2: 8.14.1-8.
6. Lipson, S. M. and G. Stotzky. 1985. Infectivity of reovirus adsorbed to
homoionic and mixed-cation clays. Water Res. 19: 227-234.
7. Lipson, S. M., M. E. Match, D. H. Shepp, M. S. Lotlikar, S Teichberg, and R.
Pergolizzi. 1998. Identification of an exogenous retrovirus
(foamy virus type
1) in rhesus monkey kidney cell cultures: significance to viral diagnostics. J.
Clin. Virol. 11: 149-153.
8. Lo, S., J. Gilbert, and Frank Hetrick. 1976. Stability of human enteroviruses in
estuarine and marine waters. Appl. Environ. Microbiol. 32: 245-249.
9. Lurton, J.,
H. Soto, A. S. Narayanan, and G. Raghu. 1999. Regulation of
human lung fibroblast C1q-receptors by transforming growth factor-beta and
tumor necrosis factor-alpha. Exp. Lung Res. 25: 151-164.. Martin, L. S., J. S.
McDougal, and S. L. Loskoski. 1985. Disinfection and inactivation of the
human T lymphotropic virus type III/lymphadenopathy-associated virus. J.
Infect. Dis. 152: 400-403.
11. MMWR. 1997. Nonhuman primate Spumavirus infections among persons
with occupational exposure - United States, 1996. 46: 129-131.
12. Murray, P. R. 1996. ASM Pocket Guide to Clinical Microbiology. Section 3.
Specimen Collection and Transport. p. 40-79. ASM Press, Washington, DC.
13. Neumann-Haefelin, D., U. Fleps, R. Renne, M. Schweizer. 1993. Foamy
viruses. Intervirology. 35: 196-207.
14. Resnick, L., K. Veren, S. K. Salahuddin, S. Tondreau, and P. Markham.
1986. Stability and inactivation of HTLV-III/LAV under clinical and laboratory
environments. JAMA. 255: 1887-1891.
15. Saifuddin, M., A. L. Landay, M. Ghassemi, C. Patki, and
G. T. Spear. 1995.
HTLV-1 activates complement leading to increased binding to complement
receptor positive cells. AIDS Res. Hum. Retroviruses. 11: 1115-1122.
16. Sandstrom, P. A., K. O. Phan, W. M. Switzer, T. Fredeking, L.
Chapman, W.
Heneine, and T. M. Folks. 2000. Simian foamy virus infection among zoo
keepers. Lancet. 355: 551-552.
17. Santillana-Hayat, M., J. Villa, M. Canivet, J. Peries, and J.-M. Molina. 1996.
Inhibition of the in vitro
infectivity and cytopathic effect of human foamy virus
by dideoxynucleosides. AIDS Res.Human Retroviruses. 12: 1485-1490.
18. Schweizer, M., R. Turek, H. Hahn, A. Schliephake, K.-O. Netzer, G. Eder, M.
Reinhardt, A. Rethwilm, and D. Neumann-Haefelin. 1995. Markers of foamy
virus infections in monkeys, apes, and accidentally infected humans:
Appropriate testing fails to confirm suspected foamy
virus prevalence in
humans. AIDS Res. Human Retroviruses. 11: 161-170.
19. Singleton, P. and D. Sainsbury. 1997. Dictionary of Microbiology and
Molecular Biology. p. John Wiley and Sons, New York.
20. Spear, G. T., N. S. Lurain, C. J. Parker, M. Ghasemi, G. H. Payne and M.
Saifuddin. 1995. Host cell-derived complement control proteins
DC55 and
CD59 are incorporated into the virions of two unrelated
enveloped viruses.
Human T cell leukemia/lymphoma virus type 1 (HTLV-I) and human
cytomegalovirus (HCMV). J. Immunol. 155:
4376-4381.
21. Stallknecht, D. E., M. T. Kearney, S. M. Shane, and P. J. Zwank. 1990.
Effects of pH, temperature, and salinity on persistence of avian influenza
viruses in water. Avian dis. 34: 412-418.
22. Stroiber, H.,
A. Clivio, and M. P. Dierich. 1997. Role of complement in HIV
infection. Ann. Rev. Immunol. 15: 649-674.
23. Wistreich, G. A. and M. D. Lechtman. 1988. Microbiology. Chapter 11.
Chemical and Physical Methods in Microbial Control. p. 314-341. Macmillan
Publishing Company, New York.